Miraculous Activist

Timothy Ray Brown, commonly referred to as the “Berlin patient,” does not want to be the only person cured of AIDS.

Written byKerry Grens
| 4 min read
timothy ray brown hiv aids activist ccr5 delta32 natural immunity

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: Timothy Ray Brown has gone from medical marvel to HIV/AIDS activist, spreading the hope that researchers can eventually develop a cure for the disease.
SCOTT TABER

In 2006, Timothy Ray Brown was bicycling through Berlin on his lunch break. He regularly cruised the city on two wheels, making a daily 14-mile round trip for work. But on this day, he got off and walked, too tired to make it back to work. “I called my partner and said, ‘I need to get an appointment with a doctor,’” Brown recalls.

Blood tests led to a bone marrow biopsy, which led to a diagnosis of acute myeloid leukemia. From there a remarkable series of circumstances—some fortuitous, others debilitating—catapulted Brown into medical history: to this day he remains the only person who has been cured of AIDS.

Cure is not a word the HIV/AIDS community throws around lightly. “Nobody would dare to use ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies